Retinal neuroprotection against ischemia-reperfusion damage induced by postconditioning

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 8, 2009, Pages 3922-3930

  Fernandez, Diego C ^a,b   Bordone, Melina P ^a   Chianelli, Mónica S ^a   Rosenstein, Ruth E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD DE MORÓN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN SYNTHESIS INHIBITOR; SYNAPTOPHYSIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; MALE; MUELLER CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; RETINA ISCHEMIA; THICKNESS; ANIMAL; CELL PROTECTION; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; INTRAOCULAR HYPERTENSION; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION; RETINA; RETINA DISEASE; WISTAR RAT;

ANIMALS; CELL SURVIVAL; CYCLOHEXIMIDE; CYTOPROTECTION; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLIAL FIBRILLARY ACIDIC PROTEIN; INTRAOCULAR PRESSURE; MALE; OCULAR HYPERTENSION; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; REPERFUSION; REPERFUSION INJURY; RETINA; RETINAL DISEASES; SYNAPTOPHYSIN; VIMENTIN;

EID: 68349113745     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3344     Document Type: Article

References (31)

1. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23(1):91-147.
2. Roth S. Endogenous neuroprotection in the retina. Brain Res Bull. 2004;62(6):461-466.
3. Roth S, Li B, Rosenbaum PS, et al. Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci. 1998;39(5):777-785.
4. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124-1136.
5. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci. 2006;7(6):437-448.
6. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285(2):H579-H588.
7. Zhao H, Sapolsky RM, Steinberg GK. Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab. 2006;26(9): 1114-1121.
8. Burda J, Danielisova V, Nemethova M, et al. Delayed postcondi-tionig initiates additive mechanism necessary for survival of selectively vulnerable neurons after transient ischemia in rat brain. Cell Mol Neurobiol. 2006;26(7-8):1141-1151.
9. Pignataro G, Meller R, Inoue K, et al. In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning. J Cereb Blood Flow Metab. 2008;28(2):232-241.
10. Wang JY, Shen J, Gao Q, et al. Ischemic postconditioning protects against global cerebral ischemia-reperfusion-induced injury in rats. Stroke. 2008;39(3):983-990.
11. Xing B, Chen H, Zhang M, et al. Ischemic post-conditioning protects brain and reduces inflammation in a rat model of focal cerebral ischemia-reperfusion. J Neurochem. 2008;105(5):1737-1745.
12. Franco PJ, Fernandez DC, Sande PH, et al. Effect of bacterial lipopolysaccharide on ischemic damage in the rat retina. Invest Ophthalmol Vis Sci. 2008;49(10):4604-4612.
13. Galagudza M, Kurapeev D, Minasian S, Valen G, Vaage J. Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm. Eur J Cardio-thorac Surg. 2004; 25(6):1006-1010.
14. Kin H, Zhao ZQ, Sun HY, et al. Postconditioning attenuates myo-cardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res. 2004; 62(1):74-85.
15. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: a form of modified reperfusion protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 2004;95(3):230-232.
16. Sun K, Liu ZS, Sun Q. Role of mitochondria in cell apoptosis during hepatic ischemia-reperfusion injury and protective effect of isch-emic postconditioning. World J Gastroenterol. 2004;10(13): 1934-1938.
17. Liu X, Chen H, Zhan B, et al. Attenuation of reperfusion injury by renal ischemic postconditioning: the role of NO. Biochem Biophys Res Commun. 2007;359(3):628-634.
18. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia. 2005;50(4):427-434.
19. Bignami A, Dahl D. The radial glia of Muller in the rat retina and their response to injury: an immunofluorescence study with antibodies to the glia fibrillary acidic (GFA) protein. Exp Eye Res. 1979;28(1):63-69.
20. Wu KH, Madigan MC, Billson FA, Penfold PL. Differential expression of GFAP in early vs. late AMD: a quantitative analysis. Br J Ophthalmol. 2003;87(9):1159-1166.
21. Erickson PA, Fisher SK, Guerin CJ, Anderson DH, Kaska DD. Glial fibrillary acidic protein increases in Muller cells after retinal detachment. Exp Eye Res. 1987;44(1):37-48.
22. Osborne NN, Block F, Sontag KH. Reduction in ocular blood flow results in glial fibrillary acidic protein (GFAP) expression in rat Muller cells. Vis Neurosci. 1991;7(6):637-639.
23. Valtorta F, Pennuto M, Bonanomi D, Benfenati F. Synaptophysin: leading actor or walk-on role in synaptic vesicle exocytosis? Bioes-says. 2004;26(4):445-453.
24. Eastwood SL, Weickert CS, Webster MJ, Herman MM, Kleinman JE, Harrison PJ. Synaptophysin protein and mRNA expression in the human hippocampal formation from birth to old age. Hippocampus. 2006;16(8):645-654.
25. Gincel D, Shoshan-Barmatz V. The synaptic vesicle protein synaptophysin: purification and characterization of its channel activity. Biophys J. 2002;83(6):3223-3229.
26. Bonanomi D, Rusconi L, Colombo CA, Benfenati F, Valtorta F. Synaptophysin I selectively specifies the exocytic pathway of syn-aptobrevin 2/VAMP2. Biochem J. 2007;404(3):525-534.
27. Ettaiche M, Heurteaux C, Blondeau N, Borsotto M, Tinel N, Laz-dunski M. ATP-sensitive potassium channels (K(ATP)) in retina: a key role for delayed ischemic tolerance. Brain Res. 2001;890(1): 118-129.
28. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol. 2004;44(5):1103-1110.
29. Darling CE, Jiang R, Maynard M, Whittaker P, Vinten-Johansen J, Przyklenk K. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol. 2005;289(4):H1618-H1626.
30. Kin H, Zatta AJ, Lofye MT, et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res. 2005;67(1):124-133.
31. Ren C, Gao X, Niu G, Yan Z, Chen X, Zhao H. Delayed postcon-ditioning protects against focal ischemic brain injury in rats. PLoS ONE. 2008;3(12):e3851.